Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
about
Roscovitine in cancer and other diseasesTherapeutic and diagnostic challenges for frontotemporal dementiaRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersChanges in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.The role of tau protein in HIV-associated neurocognitive disordersCaffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.PINCH in the cellular stress response to tau-hyperphosphorylation.Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.HIV eradication symposium: will the brain be left behind?Autophagy in dementias.Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesModeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisNeuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats.HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders.Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transferMolecular and pathologic insights from latent HIV-1 infection in the human brainNeuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity.Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation.Mass spectrometric phosphoproteome analysis of HIV-infected brain reveals novel phosphorylation sites and differential phosphorylation patterns.Infectious agents and neurodegeneration.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.HIV/neuroAIDS biomarkers.Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders.GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicityS-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117.HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
P2860
Q26799874-55998CC6-77D7-41E7-BE1C-4185E6BB10E9Q26998919-F5655867-5864-4F01-9C2C-EEC6EC543742Q27025573-757221C1-D2D9-4AEA-976F-F70D210E03A4Q28082139-04D0CDA0-C79F-4755-93EA-B291CE8D0EA8Q33924678-9EF6BC7B-E6BA-4AF9-B12E-4567A71F9978Q33936233-6F51BB90-7D5D-4D6D-8481-61629DC0AD2AQ34410713-23C3CDAE-2319-48F5-9AE5-EA4815C9B79DQ34540333-C00CB3AD-7AF0-4A77-9E50-844C2F4A351EQ34647958-8990FE97-88F9-434F-B81A-7012E2FF3995Q34914245-295581AA-7921-4508-B40C-1DD223247FF8Q35607587-854878E4-0CD0-4790-8C4E-C4AB76DA6A25Q35624697-B228A0D6-4151-466F-87F2-F79A4449FD0CQ35854093-5379DF5F-B8FA-4C39-A8BE-F66CE9F702D4Q35921136-C8D57163-9CF4-46F2-B801-6AA70D46CE0AQ36255465-004B653A-CD38-47B9-925E-B65E23FA6E9BQ36463947-277B4142-0376-4FCB-BEB8-D6624EBA13A1Q36595284-BB351FD2-64EB-4DB5-91AB-830FA974FD8CQ36869931-CD9349AA-62FE-4273-8048-348C642E284BQ36934422-44ECA9F4-C2B5-473A-A061-26C127B66F86Q37238059-DD3791F5-8BFB-45A7-A592-BE2057474326Q37401992-6CFE36B0-2D5E-4B8E-AFF0-665360CB755BQ37848266-BD0EACA7-5DE1-4AF0-8C33-F7035CD53AB4Q38625515-D0209674-9802-44AD-B9FE-1EBD09FA304AQ38809646-63F9A114-D3B6-47EE-97C9-D1DF3FB90BCEQ38868081-41B7EE75-133E-4AC8-AD0D-5F29EAA128F3Q38917051-E441FB82-BF0B-4AF7-87BB-46FF8580EBE6Q39330967-46762CF3-E32D-41A2-8816-40D5C28AC286Q42243533-1BE3BE0A-6E42-45B6-8E43-B58C478E93D1Q46229748-80402B88-2273-4DAF-9F34-12BECF2686CDQ48443596-AD49541D-7B6C-426C-AA39-4D994F0EC18CQ58750745-D13252A9-1230-4CA7-BEA3-FCA7156DA436
P2860
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@ast
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@en
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@nl
type
label
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@ast
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@en
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@nl
prefLabel
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@ast
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@en
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@nl
P2093
P2860
P1476
Increased CDK5 expression in H ...... is reversed with Roscovitine.
@en
P2093
Christina Patrick
Cristian L Achim
Ian P Everall
Leslie Crews
Paula Desplats
Wilmar Dumaop
P2860
P304
P356
10.1016/J.AJPATH.2010.12.033
P407
P577
2011-04-01T00:00:00Z